Genmab — Maj 2018
-
Did we know this from last october?: "Mabimmune and Genmab A/S are engaged in a research evaluation collaboration that involves the use of Genmab’s DuoBody
technology and Mabimmune's RTM
antibodies to generate novel bispecific antibody therapeutics." http://www.mabimmune.com/partnering -
@Cindy you made me search for others, SGEN has a presentation tonight at BoAML, maybe they'll mention TV http://investor.seattlegenetics.com/phoenix.zhtml?c=124860&p=irol-EventDetails&EventId=5271113
-
Kan vi forvente medarbejderne for solgt det hele ud i dag, eller vil udsalget fortsætte de kommende dage?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

